s6y

SANGAMO THERAPEUTICS, INC

Ticker
SGMOQ
CIK
1001233
Industry
Biological Products, (No Diagnostic Substances)
Formerly
SANGAMO BIOSCIENCES INC

Financials 111

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  2. 10-Q Quarterly Report for period ending Mar 31, 2026
  3. 10-K/A Annual Report for period ending Dec 31, 2025
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 111 financials filings

News 274

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K/A Current report filing

All 274 news filings

Ownership 1,024

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 1,024 ownership filings

Prospectus 76

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-3 Registration statement for specified transactions by certain issuers
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 76 prospectus filings

Proxies 45

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 45 proxies filings

Other 86

  1. SCHEDULE 13G/A
  2. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G
  5. 144 Filing for proposed sale of securities under Rule 144
  6. 144 Filing for proposed sale of securities under Rule 144
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G/A
  9. ARS Annual report to security holders
  10. SCHEDULE 13G/A

All 86 other filings